In2Bones gains FDA clearance for total ankle system

In2Bones on Feb. 6 received FDA approval for its Quantum total ankle system.

Advertisement

Four insights:

1. Quantum is intended for patients suffering from arthritis.

2. The total ankle system aims to improve patient mobility and stability and facilitate implant placement.

3. Quantum features a cruciate-shaped vertical stem in the tibia to enhance stability and fixation.

4. In2Bones will begin a controlled market release in the summer. Full market launch is set for the first quarter of 2021.

More articles on devices:
How will total disc replacement develop in spine? 9 spine surgeons share insights
DMC loses appeal to keep neurosurgical residency: 4 details
Neurologist found guilty in $150M fraud scheme alongside 3 other physicians

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.